Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.705 USD | -1.98% | -3.26% | -35.11% |
05-07 | Transcript : AbCellera Biologics Inc., Q1 2024 Earnings Call, May 07, 2024 | |
05-07 | AbCellera Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.11% | 1.11B | |
+34.25% | 50.85B | |
+0.37% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.94% | 26.11B | |
-21.96% | 19.13B | |
+8.85% | 13.05B | |
+26.99% | 12.16B | |
+24.38% | 12.08B |
- Stock Market
- Equities
- ABCL Stock
- News AbCellera Biologics Inc.
- AbCellera Expands Antibody Discovery Collaboration With Regeneron